YIDU TECH (02158) has bought back nearly 3.2 million shares four times in half a month, costing approximately 18.6 million Hong Kong dollars.

date
19:43 14/10/2025
avatar
GMT Eight
Medical Journey Technology announced that since September 26, the company has conducted a total of 4 buybacks, repurchasing a total of 3.1916 million shares with a total repurchase amount of 18.6359 million Hong Kong dollars.
YIDU TECH (02158) announced that on October 14, it repurchased 147.28 million shares at a price of HK $5.75-5.99 per share, with a total repurchase amount of HK $8.58 million. Since September 26, the company has conducted a total of 4 repurchases, repurchasing a total of 3.19 million shares, with a cumulative repurchase amount of HK $18.64 million. In recent news, the world's first topical treatment gel for superficial infantile hemangiomas in the proliferative phase - malysilol gel has been approved for listing. YIDU TECH provides key market research and project research analysis services, which have provided important support for the development and listing of drugs.